Company H. Lundbeck A/S

Equities

HLUN B

DK0061804770

Pharmaceuticals

Delayed Nasdaq Copenhagen 10:59:54 2024-05-17 EDT 5-day change 1st Jan Change
37.4 DKK +0.43% Intraday chart for H. Lundbeck A/S +8.16% +14.16%

Business Summary

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Number of employees: 5,681

Sales per Business

DKK in Million2022Weight2023Weight Delta
Rexulti/Rxulti
22.7 %
3,890 21.3 % 4,525 22.7 % +16.32%
Brintellix/Trintellix
21.7 %
4,277 23.4 % 4,324 21.7 % +1.10%
Other Pharmaceuticals
16.3 %
3,000 16.4 % 3,244 16.3 % +8.13%
Abilify Maintena
16.0 %
2,964 16.2 % 3,187 16.0 % +7.52%
Cipralex/Lexapro
10.7 %
2,360 12.9 % 2,135 10.7 % -9.53%
Vyepti
8.5 %
1,004 5.5 % 1,697 8.5 % +69.02%
Sabril
1.7 %
636 3.5 % 336 1.7 % -47.17%
Reconciling Items
1.6 %
277 1.5 % 327 1.6 % +18.05%
Exceptional Items
0.7 %
-588 -3.2 % 137 0.7 % -123.30%

Sales per region

DKK in Million2022Weight2023Weight Delta
United States
49.4 %
9,102 49.9 % 9,829 49.4 % +7.99%
International
25.1 %
5,203 28.5 % 4,991 25.1 % -4.07%
Europe
23.2 %
4,237 23.2 % 4,614 23.2 % +8.90%
Reconciling Items
1.6 %
277 1.5 % 327 1.6 % +18.05%
Exceptional Items
0.7 %
-588 -3.2 % 137 0.7 % -123.30%
Denmark
0.1 %
15 0.1 % 14 0.1 % -6.67%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 796,592,888 266,877,323 ( 33.50 %) 3,264,112 ( 0.4098 %) 30.74 %
Stock B 10 199,148,222 39,236,567 ( 19.70 %) 466,028 ( 0.2340 %)

Shareholders

NameEquities%Valuation
Lundbeckfonden
66.00 %
525,751,306 66.00 % 2 566 M kr
Skagen AS (Investment Management)
0.5584 %
4,447,800 0.5584 % 22 M kr
Bankinter Gestión de Activos SA SGIIC
0.3720 %
2,963,575 0.3720 % 14 M kr
Sector Gamma AS
0.2322 %
1,850,000 0.2322 % 9 M kr
Evli Fund Management Co. Ltd.
0.2284 %
1,819,420 0.2284 % 9 M kr
Canaccord Genuity Wealth Ltd.
0.1822 %
1,450,997 0.1822 % 7 M kr
Danske Bank A/S (Investment Management)
0.1693 %
1,348,778 0.1693 % 7 M kr
Nykredit Bank A/S (Investment Management)
0.1258 %
1,002,230 0.1258 % 5 M kr
Niche Asset Management Ltd.
0.0712 %
567,000 0.0712 % 3 M kr
Zadig Asset Management LLP
0.0690 %
550,000 0.0690 % 3 M kr
NameEquities%Valuation
Lundbeckfonden
80.00 %
159,318,577 80.00 % 673 M kr
Nykredit Bank A/S (Investment Management)
0.4848 %
965,535 0.4848 % 4 M kr
Argenta Spaarbank NV
0.4555 %
907,125 0.4555 % 4 M kr
Danske Bank A/S (Investment Management)
0.1739 %
346,382 0.1739 % 1 M kr
Sparinvest SA (Denmark)
0.0996 %
198,424 0.0996 % 837 748 kr
UBS Asset Management (Deutschland) GmbH
0.0835 %
166,230 0.0835 % 701 825 kr
Dimensional Fund Advisors Ltd.
0.0791 %
157,435 0.0791 % 664 692 kr
Eika Kapitalforvaltning AS
0.0773 %
153,866 0.0773 % 649 624 kr
Niche Asset Management Ltd.
0.0502 %
100,000 0.0502 % 422 201 kr
State Street Global Advisors Ltd.
0.0213 %
42,383 0.0213 % 178 941 kr

Company contact information

H. Lundbeck A/S

Ottiliavej 9

2500, Valby

+45 36 30 13 11

http://www.lundbeck.com
address H. Lundbeck A/S(HLUN B)

Group companies

NameCategory and Sector
Lundbeck Insurance A/S
  1. Stock Market
  2. Equities
  3. HLUN B Stock
  4. Company H. Lundbeck A/S
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW